U. Of I. Rockets Into Cancer Big Leagues With Rare NCI Nod
The Cancer Center at Illinois earned a rare National Cancer Institute designation in April 2026, joining a small group of lab-focused centers. The status could unlock federal infrastructure support and translational partnerships for Illinois.
Appeals Court Puts Lilly's Migraine Showdown Back In Play In Indianapolis
A federal appeals court revived Teva’s patent fight with Eli Lilly and sent the case back to Massachusetts, reopening a dispute that once produced a $176.5M jury award.
Bay Area Ad Buyers Pile On Google In High-Stakes Arbitration Blitz
Advertisers and some publishers have begun mass arbitration against Google, seeking billions after antitrust rulings that found parts of its ad tech unlawful.
Dallas Biotech Maverick Bets Big On Gene Drives To Crush Invaders
Ben Lamm says gene drives can curb a $5.4 trillion invasive‑species problem; safety and regulatory questions remain. The pitch puts Dallas biotech at the center of a fraught debate.
FBI Sounds Alarm on 'Risky' Apps Hiding in Charlotte Phones
The FBI's IC3 warns foreign-developed apps can access contacts and other device data — even for people who never installed the app. Experts and local outlets name Temu, CapCut and SHEIN as examples.
FCC Bans New Foreign-Made Wi‑Fi Routers, Explained
The FCC added foreign-made consumer routers to its Covered List, blocking new models from receiving U.S. authorization. Existing devices remain usable but future upgrades may slow.












